Cargando…
The Role of Interleukin-4 and Interleukin-10 in Osteoarthritic Joint Disease: A Systematic Narrative Review
OBJECTIVE: A fusion protein of interleukin-4 and interleukin-10 (IL4-10 FP) was developed as a disease-modifying osteoarthritis drug (DMOAD), and chondroprotection, anti-inflammation, and analgesia have been suggested. To better understand the mechanisms behind its potential as DMOAD, this systemati...
Autores principales: | van Helvoort, E.M., van der Heijden, E., van Roon, J.A.G., Eijkelkamp, N., Mastbergen, S.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251827/ https://www.ncbi.nlm.nih.gov/pubmed/35549461 http://dx.doi.org/10.1177/19476035221098167 |
Ejemplares similares
-
IL4‐10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10
por: Steen‐Louws, C., et al.
Publicado: (2018) -
IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis
Model
por: van Helvoort, E.M., et al.
Publicado: (2021) -
Role of interleukin-7 in degenerative and inflammatory joint diseases
por: van Roon, Joel AG, et al.
Publicado: (2008) -
Canine IL4-10 fusion protein provides disease modifying activity in a canine model of OA; an exploratory study
por: van Helvoort, E. M., et al.
Publicado: (2019) -
Interleukin-1 as a mediator of fatigue in disease: a narrative review
por: Roerink, Megan E., et al.
Publicado: (2017)